Skip to content

Clinical trials

Phase 2 Peripheral Vascular Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Peripheral Vascular Diseases Phase: Phase 2 Country / region: United States Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20035
20053
20062
20072
20084
20102
20111
20121
20141
20171
20181
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Terminated4
Unknown status3
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AnGes USA, Inc.2
Valentis2
ARCA Biopharma, Inc.1
ActivBiotics1
AstraZeneca1
Biotronik, Inc.1
Celgene Corporation1
Endovasc1
FoxHollow Technologies1
Genzyme, a Sanofi Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Peripheral Vascular Diseases24
Peripheral Arterial Disease9
Chronic Limb-Threatening Ischemia8
Intermittent Claudication5
Arterial Occlusive Diseases4
Ischemia4
Atherosclerosis2
Cardiovascular Diseases2
Coronary Artery Disease2
Arteriosclerosis1

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.